JPH11500901A - 連鎖球菌属からのリポテイコ酸を含有する抗腫瘍及び抗コレステロール製剤 - Google Patents
連鎖球菌属からのリポテイコ酸を含有する抗腫瘍及び抗コレステロール製剤Info
- Publication number
- JPH11500901A JPH11500901A JP8523227A JP52322796A JPH11500901A JP H11500901 A JPH11500901 A JP H11500901A JP 8523227 A JP8523227 A JP 8523227A JP 52322796 A JP52322796 A JP 52322796A JP H11500901 A JPH11500901 A JP H11500901A
- Authority
- JP
- Japan
- Prior art keywords
- lta
- lipoteichoic acid
- new
- acid
- streptococcus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/51—Lyases (4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
- C07H15/06—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical being a hydroxyalkyl group esterified by a fatty acid
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/44—Preparation of O-glycosides, e.g. glucosides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/885—Streptococcus
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.新規な連鎖球菌属の種PT株DSM 8747から単離し得る新規な精製リポテイコ 酸(LTA)。 2.式I (式中、R1は水素またはリンに対するモル比が0.27〜0.35のD−アラニルで、 R2は炭素原子12,14,16または18の飽和または不飽和脂肪酸の残基であって、 nの平均値は9である)の請求項1に記載のリポテイコ酸 LTA−T及びそれらの 塩。 3.請求項1に記載のリポテイコ酸であって、生理的に許容し得る塩、たとえ ば陽荷電したイオンからの、たとえばアルカリ金属もしくはアルカリ土金属イオ ン、または陽荷電した第1級、第2級、第3級もしくは第4級アンモニウムイオ ン(酸付加塩)、たとえばナトリウム、カリウム、カルシウム、亜鉛、アンモニ ウム、モノ−、ジ−、トリ−もしくはテトラ−低級アルキル、たとえばメチル− もしくはエチルまたはメチル−エチル−、プロピルもしくはブチル−アンモニウ ムイオン、特にナトリウムイオンからの塩の形で存在 するリポテイコ酸。 4.慣用の方法による連鎖球菌属の種(DSM 8747)から、リポテイコ酸 LTA− Tを単離することを特徴とする、請求項1に記載のリポテイコ酸 LTA−Tの調製 方法。 5.請求項1に記載のリポテイコ酸またはその生理的に許容し得る塩を投薬単 位形態に含んでなる医薬製剤。 6.アルファ−インターフェロンと組み合せた請求項5に記載の医薬製剤。 7.ヒアルロニダーゼと組み合せた請求項5に記載の医薬製剤。 8.インターフェロン−アルファ及びヒアルロニダーゼと組み合せた請求項5 に記載の医薬製剤。 9.慣用の方法による、請求項1に記載のリポテイコ酸を含む医薬製剤を製造 する方法。 10.抗腫瘍有効量の請求項1に記載のリポテイコ酸 LTA−Tまたはその生理的 に許容し得る塩を、腫瘍またはその悪性の細胞を病んでいる患者に投与すること を含んでなる癌の治療方法。 11.コレステロールを低下させる量の請求項に記載の LTAまたはその生理的に 許容し得る塩をそれを必要とするヒト患者に投与することを含んでなる、ヒト患 者の血液コレステロール値を低下させる方法。 12.新規な連鎖球菌属の種PT株DSM 8747。 13.連鎖球菌属の種 PT DSM 8747を増殖させる方法であって、前記細菌株を増 殖条件下に増殖させることを特徴とする方法。 14.R1及びR2が両方共水素であって、nは示された意味を有する、請求項2 に記載の式Iの脱アシル化dLTA−Tまたはその塩。 15.式II (式中、R2は炭素原子12,14,16または18の飽和または不飽和脂肪酸の残基で ある)のベータ−ガラクトフラノシル(1−3)グリセロール−ジ−R2−エス テル、その個々の化合物及びそれらの塩。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP95101208 | 1995-01-30 | ||
GB95101208.7 | 1995-01-30 | ||
PCT/EP1996/000309 WO1996023896A1 (en) | 1995-01-30 | 1996-01-24 | Antitumor and anticholesterol preparations containing a lipoteichoic acid from steptococcus |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH11500901A true JPH11500901A (ja) | 1999-01-26 |
JP3638955B2 JP3638955B2 (ja) | 2005-04-13 |
Family
ID=8218940
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP52322796A Expired - Fee Related JP3638955B2 (ja) | 1995-01-30 | 1996-01-24 | 連鎖球菌属からのリポテイコ酸を含有する抗腫瘍及び抗コレステロール製剤 |
Country Status (11)
Country | Link |
---|---|
US (2) | US6114161A (ja) |
EP (1) | EP0807185B9 (ja) |
JP (1) | JP3638955B2 (ja) |
CN (1) | CN1113102C (ja) |
AT (1) | ATE219146T1 (ja) |
AU (1) | AU4714196A (ja) |
CA (1) | CA2208780C (ja) |
DE (1) | DE69621776T2 (ja) |
DK (1) | DK0807185T3 (ja) |
ES (1) | ES2178699T3 (ja) |
WO (1) | WO1996023896A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010538054A (ja) * | 2007-09-07 | 2010-12-09 | イシス イノベーション リミテッド | 胸水貯留または気胸の処置において使用するためのリポテイコ酸を含む組成物 |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3638955B2 (ja) * | 1995-01-30 | 2005-04-13 | トルオク,ペーター | 連鎖球菌属からのリポテイコ酸を含有する抗腫瘍及び抗コレステロール製剤 |
US6610293B1 (en) * | 1997-06-16 | 2003-08-26 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine | Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria |
DE19728900A1 (de) * | 1997-07-07 | 1999-01-14 | Henkel Kgaa | Hydrophile Glykoside |
JP4490581B2 (ja) * | 1998-04-02 | 2010-06-30 | ボード オブ リージェンツ オブ ザ ユニヴァーシティー オブ オクラホマ | ヒアルロナンシンターゼをコードする核酸およびその使用方法 |
KR20040021697A (ko) | 2001-08-13 | 2004-03-10 | 유니버시티 오브 플로리다 리서치 파운데이션, 인크. | 신경 조직 복구를 증진시키는 물질 및 방법 |
EP1521523A4 (en) * | 2002-05-20 | 2006-04-19 | Univ Texas | METHODS AND COMPOSITIONS FOR DELIVERING NUCLEIC ACID ENZYMES AND MOLECULES IN BRAIN, BONE, AND OTHER FABRICS |
KR100443080B1 (ko) * | 2002-07-11 | 2004-08-04 | 일동제약주식회사 | 콜레스테롤 저하능을 갖는 스트렙토코커스 페시움 균주 |
WO2004050846A2 (en) * | 2002-12-02 | 2004-06-17 | Biosynexus Incorporated | Wall teichoic acid as a target for anti-staphylococcal therapies and vaccines |
CN105440133A (zh) | 2009-07-15 | 2016-03-30 | Aimm医疗股份公司 | ***特异性结合化合物 |
EP2471801A4 (en) * | 2009-08-26 | 2013-12-04 | Rna Inc | GLYCOLIPIDES DERIVED FROM LIPOTHEICHOIC ACID AND COMPOSITIONS CONTAINING THESE GLYCOLIPIDS |
EP2380565A1 (en) | 2010-03-31 | 2011-10-26 | Lunamed AG | Compositions for dental treatment comprising Lipoteichoic acids or parts thereof like mono- or polyglycerphosphates |
ES2544808T3 (es) * | 2011-03-11 | 2015-09-04 | Universitätsklinikum Freiburg | Miméticos sintéticos de LTA y uso de los mismos como componente de vacuna para la terapia y/o profilaxis de infecciones gram-positivas |
EP2545911A1 (en) | 2011-07-12 | 2013-01-16 | Lunamed AG | Use of Lipoteichoic Acid in the Treatment of Non-Encapsulated Cancer Cells |
EP2545910A1 (en) | 2011-07-12 | 2013-01-16 | Lunamed AG | Use of Lipoteichoic Acid in the treatment of cancer in an inflammatory state |
EP2545909A1 (en) | 2011-07-12 | 2013-01-16 | Lunamed AG | Combination of D-Amino Acids and Lipoteichoic Acid |
EP2574237A1 (en) | 2011-09-30 | 2013-04-03 | Lunamed AG | Use of a lipoteichoic acid, mono- or polyglycerophosphate for antibacterial pre-treatment and especially in medical devices |
EP2589388A1 (en) | 2011-11-04 | 2013-05-08 | Lunamed AG | Use of a Teichoic acid for the treatment of malignant ascites |
EP2589387A1 (en) | 2011-11-04 | 2013-05-08 | Lunamed AG | Use of a teichoic acid for the treatment of malignant liquor cerebrospinalis in the brain |
KR102259799B1 (ko) * | 2018-06-01 | 2021-06-02 | 경희대학교 산학협력단 | 리포테이코익산, TNF-α 및 IFN-γ를 유효성분으로 함유하는 항암용 조성물 |
KR20190137397A (ko) * | 2018-06-01 | 2019-12-11 | 경희대학교 산학협력단 | 리포테이코익산, TNF-α 및 IFN-γ를 유효성분으로 함유하는 항암용 조성물 |
US20230042693A1 (en) | 2019-12-27 | 2023-02-09 | Biopolis, S.L. | Uses of lipoteichoic acid from bifidobacteria |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3729461A (en) * | 1970-12-23 | 1973-04-24 | Us Agriculture | Synthesis of glycosyl glycerides |
SU787414A1 (ru) * | 1978-10-05 | 1980-12-15 | Московский Ордена Трудового Красного Знамени Институт Тонкой Химической Технологии Им. М.В. Ломоносова | Способ получени 1,2-ди-0-пальмитоил- 3-0-/6-0-(1,2-ди-0-пальмитоил- - глицеро-3-0-фосфорил)- - глюкопиранозил/- -глицерина |
US4678773A (en) * | 1983-08-26 | 1987-07-07 | Chugai Seiyaku Kabushiki Kaisha | Antitumor agent |
JPS61275217A (ja) * | 1985-05-29 | 1986-12-05 | Yakult Honsha Co Ltd | グラム陰性桿菌感染症防御剤 |
JPS6456692A (en) * | 1987-08-27 | 1989-03-03 | Nisshin Oil Mills Ltd | Production of sugar glycerol |
JPS6467237A (en) * | 1987-09-09 | 1989-03-13 | Nisshin Oil Mills Ltd | Novel surface active composition and emulsified composition combined therewith |
NL9100510A (nl) * | 1991-03-21 | 1992-10-16 | Centraal Diergeneeskundig Inst | Dna-sequenties die coderen voor kenmerken van virulentie van streptococcus suis en delen daarvan, daarvan afgeleide polypeptiden en antilichamen, alsmede toepassing daarvan bij de diagnose van en de bescherming tegen infectie met s. suis bij zoogdieren, waaronder de mens. |
WO1994020115A2 (en) * | 1993-03-10 | 1994-09-15 | Miles, Inc. | Hyaluronic acid used as a cancer treatment |
JP3638955B2 (ja) * | 1995-01-30 | 2005-04-13 | トルオク,ペーター | 連鎖球菌属からのリポテイコ酸を含有する抗腫瘍及び抗コレステロール製剤 |
-
1996
- 1996-01-24 JP JP52322796A patent/JP3638955B2/ja not_active Expired - Fee Related
- 1996-01-24 US US08/875,018 patent/US6114161A/en not_active Expired - Lifetime
- 1996-01-24 AU AU47141/96A patent/AU4714196A/en not_active Abandoned
- 1996-01-24 ES ES96902922T patent/ES2178699T3/es not_active Expired - Lifetime
- 1996-01-24 CA CA2208780A patent/CA2208780C/en not_active Expired - Fee Related
- 1996-01-24 WO PCT/EP1996/000309 patent/WO1996023896A1/en active IP Right Grant
- 1996-01-24 DE DE69621776T patent/DE69621776T2/de not_active Expired - Lifetime
- 1996-01-24 CN CN96191668A patent/CN1113102C/zh not_active Expired - Fee Related
- 1996-01-24 EP EP96902922A patent/EP0807185B9/en not_active Expired - Lifetime
- 1996-01-24 DK DK96902922T patent/DK0807185T3/da active
- 1996-01-24 AT AT96902922T patent/ATE219146T1/de active
-
1999
- 1999-01-15 US US09/232,106 patent/US6214978B1/en not_active Expired - Lifetime
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2010538054A (ja) * | 2007-09-07 | 2010-12-09 | イシス イノベーション リミテッド | 胸水貯留または気胸の処置において使用するためのリポテイコ酸を含む組成物 |
Also Published As
Publication number | Publication date |
---|---|
DE69621776D1 (de) | 2002-07-18 |
WO1996023896A1 (en) | 1996-08-08 |
US6114161A (en) | 2000-09-05 |
EP0807185A1 (en) | 1997-11-19 |
DE69621776T2 (de) | 2003-01-30 |
EP0807185B1 (en) | 2002-06-12 |
ATE219146T1 (de) | 2002-06-15 |
DK0807185T3 (da) | 2002-10-07 |
AU4714196A (en) | 1996-08-21 |
JP3638955B2 (ja) | 2005-04-13 |
CN1173206A (zh) | 1998-02-11 |
EP0807185B9 (en) | 2002-12-11 |
CN1113102C (zh) | 2003-07-02 |
CA2208780A1 (en) | 1996-08-08 |
US6214978B1 (en) | 2001-04-10 |
ES2178699T3 (es) | 2003-01-01 |
CA2208780C (en) | 2010-03-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3638955B2 (ja) | 連鎖球菌属からのリポテイコ酸を含有する抗腫瘍及び抗コレステロール製剤 | |
US3956481A (en) | Hydrosoluble extracts of mycobacteria, their preparation and use | |
DE69032206T2 (de) | Lipid-a-derivate sowie deren verwendungen | |
Shnyra et al. | Role of the physical state of Salmonella lipopolysaccharide in expression of biological and endotoxic properties | |
JPS6241601B2 (ja) | ||
KR100197446B1 (ko) | 펠리누스 린테우스로부터 분리된 항암 면역활성 다당류 및 이의 제조 방법 | |
AU655425B2 (en) | Immunostimulant drug based on polar glycopeptidolipids of mycobacterium chelonae | |
US4614733A (en) | Polysaccharides pharmaceutical compositions and the use thereof | |
JP2007039341A (ja) | フコイダン由来オリゴ糖 | |
JP2001504144A (ja) | Gbsトキシン/cm101の精製方法 | |
US4001395A (en) | Hydrosoluble extracts of mycobacteria | |
JPS6316118B2 (ja) | ||
EP0991773B1 (en) | Carbohydrate complex extracted from mycobacterium tuberculosis and process for the preparation thereof | |
JPS58318B2 (ja) | 制癌性物質の製造方法 | |
KR20010029544A (ko) | 천연형 항종양성 또는 항바이러스성 물질 및 이의 용도 | |
JP2002179577A (ja) | 抗腫瘍物質及び抗腫瘍剤 | |
US6274356B1 (en) | Carbohydrate complex extracted from Mycobacterium tuberculosis and process for the preparation thereof | |
KR20020010242A (ko) | 느릅나무로부터 분리된 신규의 미생물 및 그를 이용한항암 면역활성의 세포밖 당화합물의 제조방법 | |
HU210826B (en) | Process for the preparation of an extracellular exopolymer and pharmaceutical compositions containing the same | |
JP3688446B2 (ja) | 新規テルペン系化合物0406tp−1 | |
FR2650506A1 (fr) | Galactanne extrait de klebsiella, procede d'obtention et application a titre de medicament | |
JP4500008B2 (ja) | 新規な二糖類、それを含有する組成物及びその製造方法 | |
JP2519074B2 (ja) | α,α−トレハロ−ストリミコ−ル酸エステルおよび医薬組成物 | |
JPH10273496A (ja) | リポタイコ酸 | |
EP0799235A1 (en) | Methods for the preparation of pure homologous series of mono to tetra fatty acyl esters of sugars; characterization of one antitumor component as maltose 1, 6, 6' tripalmitate: and pharmaceutical formulations useful in the treatment of cancer. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20040510 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20040622 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20040819 |
|
RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20040819 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20041012 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20041214 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20050113 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R154 | Certificate of patent or utility model (reissue) |
Free format text: JAPANESE INTERMEDIATE CODE: R154 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080121 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090121 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100121 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100121 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110121 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110121 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120121 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120121 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130121 Year of fee payment: 8 |
|
LAPS | Cancellation because of no payment of annual fees |